Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Christoph Heining

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1256-8387; OpenAlex author ID A5061025683. Sources: ClinicalTrials.gov.

Their work

Papers
2
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 trial · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. 17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing? Co-author DOI 10.1016/j.esmogo.2025.100218↗
  2. NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-18-0036↗

Trials 1

  1. Afatinib in Advanced NRG1-Rearranged Malignancies Principal investigator NCT04410653↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Karl Roland Ehrenberg · 1 shared paper, 2018 · strength 0.05
  2. Nathalia A. Giese · 1 shared paper, 2018 · strength 0.05
  3. Wilko Weichert · 1 shared paper, 2018 · strength 0.05
  4. Claudia R. Ball · 1 shared paper, 2018 · strength 0.05
  5. Thilo Hackert · 1 shared paper, 2018 · strength 0.05
  6. Marius Horger · 1 shared paper, 2018 · strength 0.05
  7. Christoph Springfeld · 1 shared paper, 2018 · strength 0.05
  8. Hanno Glimm · 1 shared paper, 2018 · strength 0.05
  9. Oliver Strobel · 1 shared paper, 2018 · strength 0.05
  10. Albrecht Stenzinger · 1 shared paper, 2018 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.